ArticleExperimental and therapeutic medicine2024

KLF9‑regulated FBXO31 inhibits the progression of endometrial cancer and enhances the sensitivity of endometrial cancer cells to cisplatin.

Mudan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.